2 edition of Oral mucositis and quality of life in allogeneic bone marrow transplant patients found in the catalog.
Oral mucositis and quality of life in allogeneic bone marrow transplant patients
Jennifer A. Kushner
Written in English
|Statement||by Jennifer A. Kushner.|
|The Physical Object|
|Pagination||vii, 77 leaves.|
|Number of Pages||77|
Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer ; – Article. To assess the relationship between oral mucositis (OM) and adverse clinical and economic outcomes in patients with hematologic malignancies receiving allogeneic hematopoietic stem-cell transplantation (HSCT). A retrospective chart review study of allogeneic HSCT recipients with hematologic malignancies was undertaken at a single .
Hematopoietic stem cell transplantation (HSCT) is widely used as a potentially curative treatment for patients with various hematological malignancies, bone marrow failure syndromes, and congenital immune deficiencies. The prevalence of oral complications in both autologous and allogeneic HSCT recipients remains high, despite advances in transplant medicine and in . Comparison of early quality of life outcomes in autologous and allogeneic transplant patients Garcia, C. M.; Mumby, P. B.; Thilges, S.; Stiff, P. J., Bone marrow transplantation Predictors of non-compliance in autologous hematopoietic SCT patients undergoing out-patient transplants.
The incidence of oral mucositis in either autologous or allogeneic transplant is high and is reported to vary from 75% to 99%. use of opioid analgesics, improvement in oral intake, improvement in quality of life, and reduction in duration of hospitalization. randomized clinical trial in 95 bone marrow transplant patients Results.  Weisdorf DJ, et al: Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse. Bone Marrow Transpl ;  Ferretti GA, et al: Control of oral mucositis and candidiasis in marrow transplantation: a prospective, double-blind.
The 2000 Import and Export Market for Preparations of Cereal and Fruit and Vegetable Flours in Oceana (World Trade Report)
Mozart the musician.
Dump-27 Rh Dict-Canada
Explorations in Economics
Rural lines, USA
Groundwater protection through local land-use controls. by Douglas A. Yanggen and Bruce Webendorfer
Moby Dick (Pacemaker Classics (Audio))
Donald Lines Jacobus index to genealogical periodicals.
Peanut Butter Pilgram
Crippled childrens services
Jane R. McQuaide.
Hamlyn encyclopedia of space
Introduction. Oral mucositis (OM) is one of the most frequent and important side effects of many anticancer therapies and has a significant physical and psychological impact for a large number of patients treated for neoplasias. The most important consequences of OM are pain, dysphagia, requirement of parenteral nutrition, increased risk of mucosal and systemic infections, poor quality Cited by: 3.
Oral Mucositis Assessment Scale (OMAS) as a predictor of clinical and economic outcomes in bone marrow transplant patients Blood Cited by: BACKGROUND AND OBJECTIVE: Oral mucositis, a painful condition with potentially life-threatening sequelae, often develops in association with allogeneic bone marrow transplantation.
This condition has an adverse impact on the oral-health-related quality of life of patients undergoing marrow transplantation by: Oral mucositis (OM) is a common side effect experienced during haematopoietic SCT (HSCT), and it can have a significant impact on the quality of life of patients.
A descriptive nurse-led study was Cited by: Oral mucositis is a painful condition that occurs in 80% of patients who undergo haematopoietic stem cell transplantation (HSCT). Our objective was to determine the impact of mucositis on quality of life (QoL) of patients subjected to HSCT treated with low‐level laser therapy (LLLT).Cited by: To explore the best schedule of oral cryotherapy for the prevention of oral mucositis in recipients of myeloablative hematopoietic stem cell transplantation (HSCT).
A prospective randomized study was conducted to recruit allogeneic HSCT recipients, who were then randomly allocated into four arms to accept the following: oral cryotherapy during the.
Oral mucositis occurs in up to 75% of recipients of high-dose chemoradiotherapy conditioning regimens used for allogeneic hematopoietic stem cell transplantation (HSCT). As a result of mucositis, narcotic analgesia and total parenteral nutrition (TPN) are commonly required after HSCT.
Methotrexate, an antiproliferative graft-versus-host disease (GVHD) prophylaxis agent. Introduction. Oral mucositis (OM) is defined as inflammation of the mucosa oral cavity, and is clinically characterized by the presence of erythematous areas that subsequently merge with ulcerations ().Oral mucositis is caused by destruction of the oral mucosal epithelium and suppression of its growth secondary to antineoplastic treatment in the form of.
Recovery and Quality of Life. To assess functional recovery of survivors, we focused on 83 patients with at least 6 months follow-up after transplant. Eighteen patients (22%) died from NRM causes at a median of days post-transplant (range, to ).
These patients tended to have a complicated course. 1. Introduction. Oral mucositis (OM) refers to erythematous and painful ulcerative lesions of the oral mucosa observed in patients with cancer, who are treated with chemotherapy, and/or with radiation therapy .According to the majority of studies, this complication occurs in up to 80% of patients receiving high-dose chemotherapy, and in up to % of patients.
Quality of life and psychological distress of bone marrow transplant recipients: the ‘time trajectory’ to recovery over the first year Bone Marrow Transplant.
Oral mucositis (OM) is a debilitating early adverse effect of allogeneic hematopoietic stem cell transplantation (HSCT). The intensity of the conditioning regimen correlates with the incidence and severity of OM, but no studies have analyzed this relationship among various conditioning regimens.
We performed a systematic review on the incidence and outcomes of OM in allogeneic HSCT patients. Background: Patients who receive hematopoietic stem cell transplantation (HSCT) experience several complications that oral mucositis (OM) is a frequent symptom.
This study was designed to evaluate the incidence, risk factors, prophylaxis and treatment strategies for established OM. Materials and Methods: We included adult patients who received autologous or allogeneic.
Patients with oral mucositis and neutropenia (a type of white blood cell deficiency) have a relative risk of septicemia (a systemic, toxic illness caused by the invasion of the bloodstream by virulent bacteria coming from a local infection) more than 4 times that of patients.
Silva LC, Sacono NT, Freire Mdo C, et al. The Impact of Low-Level Laser Therapy on Oral Mucositis and Quality of Life in Patients Undergoing Hematopoietic Stem Cell Transplantation Using the Oral Health Impact Profile and the Functional Assessment of Cancer Therapy-Bone Marrow Transplantation Questionnaires.
Photomed Laser Surg ; transplant patients”, “oral complications of pediatric bone marrow transplantation”, “oral complications of pediatric hematopoietic stem cell transplantation”, “oral mucositis and bone marrow transplantation” and “stomatitis and bone marrow transplantation”.
Expert opinion and that can compromise the child’s quality of. Oral mucositis is a significant problem for most HSCT recipients and has been reported to be the most debilitating side effect of transplantation.
[3, 4] Mucositis has immediate detrimental effects on patient quality of life by causing oral and oropharyngeal pain and by impairing communication and swallowing.
As a result of pain related to. Emmanouilides C, Spielberger R, Stiff P, Rong A, et al. Palifermin Treatment of Mucositis in Transplant Patients Reduces Health Resource Use: Phase 3 Results. Proc Am Soc Hem. Blood. ;(11)a, Abstract # 4. Syrjala KL, Hays RD, Kallich JD, Farivar SS, et al.
Impact of Oral Mucositis and Its Sequelae on Quality of Life. Proc Am. L.C. Silva, N.T. Sacono, C. Freire Mdo, L.R. Costa, A.C. Batista, G.B.
SilvaThe impact of low-level laser therapy on oral mucositis and quality of life in patients undergoing hematopoietic stem cell transplantation using the Oral Health Impact Profile and the Functional Assessment of Cancer Therapy-Bone Marrow Transplantation questionnaires.
Introduction. Oral mucositis (OM) is a debilitating adverse effect of treatment during allogeneic hematopoietic stem cell transplantation (HSCT) and its incidence varies between 47% and %, depending on a multitude of rmore, OM is 1 of the most common complications and is often a dose-limiting toxicity among patients undergoing.
Langner S, Staber P, Schub N, et al. Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients. Bone Marrow Transplant ; Hensley ML, Hagerty KL, Kewalramani T, et al.
American Society of Clinical Oncology clinical practice guideline update: use of chemotherapy and radiation.Little is known about the effects of professional oral health care (POHC) on the outcome of hematopoietic stem cell transplantation (HSCT).
We evaluated the effects of POHC given by dentists and dental hygienists on the development of oral mucositis and febrile neutropenia (FN) after allogeneic bone marrow transplantation (BMT).
We retrospectively studied adult patients. Since most patients undergoing high-dose chemotherapies for solid tumors, bone marrow transplant, and radiation for head and neck cancer will develop oral mucositis, it is advised that these.